Literature DB >> 5219579

A biopsy series of mesotheliomata, and attempts to identify asbestos within some of the tumors.

D O Hourihane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5219579     DOI： 10.1111/j.1749-6632.1965.tb41143.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Peritoneal mesothelioma following pneumoperitoneum maintained for twelve years. Report of a case.

Authors:  J W Brown; K A Kristensen; L S Monroe
Journal:  Am J Dig Dis       Date:  1968-09

2.  Chronic effects of ingested asbestos in rats.

Authors:  H M Cunningham; C A Moodie; G A Lawrence; R D Pontefract
Journal:  Arch Environ Contam Toxicol       Date:  1977       Impact factor: 2.804

3.  Pulmonary response and transmigration of inorganic fibers by inhalation exposure.

Authors:  K P Lee; C E Barras; F D Griffith; R S Waritz
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

4.  Acute and chronic effects of intraperitoneal injection of two types of asbestos in rats with a study of the histopathogenesis and ultrastructure of resulting mesotheliomas.

Authors:  M L Shin; H I Firminger
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

5.  Benign pleural lesion and malignant mesothelioma.

Authors:  M Klima; F Gyorkey
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-25

6.  Clearance of asbestos bodies from the lung: a personal view.

Authors:  K J Arul; P F Holt
Journal:  Br J Ind Med       Date:  1980-08

7.  Asbestos-induced peritoneal mesothelioma in a construction worker.

Authors:  Rodolfo Fonte; Salvatore Gambettino; Mario Melazzini; Mario Scelsi; Claudio Zanon; Stefano M Candura
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031

8.  Migration of asbestos fibres from subcutaneous injection sites in mice.

Authors:  K Kanazawa; M S Birbeck; R L Carter; F J Roe
Journal:  Br J Cancer       Date:  1970-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.